(MedPage Today) — “Sneaky” senescent cells that promote treatment resistance could prove to be a target for new lung cancer therapies, researchers said. (UCSF Health, Cell Stem Cell)
Competition is heating up in the race to market the first bispecific…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/118527
Author :
Publish date : 2025-11-14 16:37:00
Copyright for syndicated content belongs to the linked Source.
